Current Edition

breast

Tecentriq extends streak with win in breast cancer trial

Roche’s checkpoint inhibitor Tecentriq helped extend progression-free survival in a Phase 3 study of patients with a hard-to-treat form of metastatic breast cancer, a milestone …

Continue Reading →